Objective To observe and compare the volumes and survival periods of tumors in the patients with advanced liver cancer after treatments of transhepatic arterial infusion and heat infusion.
目的经肝动脉介入性灌注与热灌注化疗治疗中晚期肝癌，观察对比病灶大小、生存期。
The rat model of alcoholic liver fibrosis was induced by intragastric infusion of increasing concentration of ethanol 3 times per day.
通过递增乙醇浓度，日3次胃内灌注乙醇来复制酒精性肝纤维化动物模型。
AIM: To evaluate the efficacy of hepatic arterial infusion chemotherapy (HAIC) based on oxaliplatin for treatment of the patients with multiple liver metastases from colorectal cancer.
目的：探讨以奥沙利铂为主的肝动脉灌注化疗对结直肠癌多发肝转移患者的治疗效果。
Object To observe the therapeutic effect of hepatic arterial infusion and embolization assisted microwave in the treatments of patients with liver cancer.
目的观察肝癌患者动脉灌注与栓塞配合热疗的治疗效果。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
CONCLUSION: Donor specific bone marrow infusion enhances chimerism formation in bone marrow, alleviates the rejection of liver allotransplantation and improve survival of liver allotransplantation.
结论：供体骨髓输注可形成供受体细胞的嵌合状态，可降低同种异体肝移植的排斥反应，延长受体生存时间。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Objective:To observe the clinical therapeutic of Prescription Radix Injection(PRI)hepatic arterial infusion therapy mid-late stage liver cancer.
目的：观察复方苦参注射液肝动脉灌注治疗中晚期肝癌的临床疗效。
Methods:48 patients with advanced liver cancer were treated by transcatheter hepatic arterial infusion of drugs and active cares were given to the patients according to individual problem.
方法：对48例肝癌患者严密临床观察，包括生命体征及辅助性用药，并实施针对性护理措施。
Conclusion Liver tissues and structures varied by HL-1 quick intravenous infusion. The promotion in ultrasound attenuation and absorption indicated a shift of acoustic environment.
结论静脉快速输入HL - 1可使兔肝脏组织结构发生相应的变化，使肝脏声吸收衰减增加，因而改变了肝脏组织声学环境。
Treatment should be comprehensively considered by improving liver function, treatment of original liver disease, albumin infusion and rational use of antibiotics.
治疗上应该从改善肝功能、处理肝脏原发病、补充白蛋白和合理使用抗生素等诸方面综合考虑。
Treatment should be comprehensively considered by improving liver function, treatment of original liver disease, albumin infusion and rational use of antibiotics.
治疗上应该从改善肝功能、处理肝脏原发病、补充白蛋白和合理使用抗生素等诸方面综合考虑。
应用推荐